Clinical trial to assess the efficacy of adapalene for hand-foot syndrome (HFS) in patients of metastatic breast cancer - Clinical trial to assess the efficacy of adapalene for hand-foot syndrome (HFS) induced by capecitabine in patients of metastatic breast cancer

Department of gastroenterologic and breast surgery Kanazawa University,School of Medicine0 个研究点目标入组 40 人开始时间: 2013年9月17日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Past history of allergic reaction 2)Active secondary malignancies 3)Pregnancy or suspected pregnancy 4)Uncontralled severe infection 5)severe complications (uncontrolled hypertension, angina pectoris, congestive heart disease, liver failure, prior myocardial infarction in less than a year, arrhythmia requiring treatment, or bleeding tendency) 6)Dyspnea requiring oxygen therapy because of interstitial pneumonia or pulmonary fibrosis 7)Symptomatic brain metastasis 8)Uncontrolled diabetes mellitus 9)Severe pleural effusion or ascites 10)Physician judged improper to entry this trial

发起方

Department of gastroenterologic and breast surgery Kanazawa University,School of Medicine